Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biotechnology company with ...

Tonix Pharmaceuticals (NASDAQ: TNXP) presented new data at the 2025 Annual European Congress of Rheumatology (EULAR) in Barcelona supporting TNX-102 ...

3 mg and Tosymra® (sumatriptan nasal spray) 10 mg for the treatment of acute migraine with or without aura in adults. * Tonix's product development candidates are investigational new drugs or ...

Tonix Medicines, our commercial subsidiary, markets Zembrace (sumatriptan nasal spray) 10 mg for the treatment of acute migraine with or without aura in adults. * Tonix’s product development ...

Sumatriptan – Imitrex® 25, 50, 100 mg tablets 5, 20 mg nasal spray, 4, 6 mg/0.5 ml cartridges; 6 mg/0.5 ml vials 50 or 100 mg p.o.; can be repeated after 2 h (max 200 mg/day), 5, 10 or 20 mg ...

3 mg and Tosymra® (sumatriptan nasal spray) 10 mg for the treatment of acute migraine with or without aura in adults. * Tonix's product development candidates are investigational new drugs or ...

More migraine treatments than ever have become available in recent years, with more on the way. Discover the many options ...

Dihydroergotamine (DHE) is an older drug used for migraine relief. Learn about new formulations and find out if you're a good candidate for this powerful treatment.